Wiskostatin and Its Effects on Cell Division
Author Information
Author(s): Bompard Guillaume, Rabeharivelo Gabriel, Morin Nathalie
Primary Institution: CRBM, CNRS UMR 5237, Université Montpellier I et II
Hypothesis
Does wiskostatin inhibit cytokinesis through the N-WASP/Arp2/3 complex pathway?
Conclusion
Wiskostatin inhibits cytokinesis without affecting mitosis, suggesting it targets other proteins involved in the process.
Supporting Evidence
- Wiskostatin treatment led to 85% of cells being binucleated.
- Control cells showed only 7% binucleation.
- Wiskostatin did not affect the degradation of cyclin B1 during mitosis.
- Arp2/3 complex localization was reduced in the contractile ring under wiskostatin treatment.
- Wiskostatin's effects were not replicated by alternative inhibition of the N-WASP/Arp2/3 pathway.
Takeaway
Wiskostatin is a chemical that stops cells from dividing properly, making them have two nuclei instead of one.
Methodology
HeLa cells were treated with wiskostatin and analyzed for DNA content and binucleation through flow cytometry and immunoblotting.
Potential Biases
Potential bias in interpreting the effects of wiskostatin due to its multiple targets.
Limitations
The study did not explore all potential targets of wiskostatin beyond N-WASP.
Participant Demographics
HeLa cells, a human cervical cancer cell line.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website